Atsushi Takeda, MD, PhD

Medical Biochemistry Tohoku University, Sendai-shi, Miyagi-ken, Japan 
"Atsushi Takeda"
Mean distance: 18.77 (cluster 28)
Cross-listing: Alzheimer's Tree - Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kanno S, Shinohara M, Kanno K, et al. (2020) Neural substrates underlying progressive micrographia in Parkinson's disease. Brain and Behavior. e01669
Gang M, Baba T, Hosokai Y, et al. (2020) Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society
Baba T, Takeda A. (2020) Cognitive impairment and its association with cholinergic dysfunction in Parkinson’s disease Neurology and Clinical Neuroscience
Kobayashi J, Hasegawa T, Sugeno N, et al. (2019) Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802051R
Ezura M, Kikuchi A, Ishiki A, et al. (2019) Longitudinal changes in F-THK5351 PET in corticobasal syndrome. European Journal of Neurology
Nomoto M, Nagai M, Nishikawa N, et al. (2018) Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease. Eneurologicalsci. 13: 8-13
Hattori N, Takeda A, Takeda S, et al. (2018) Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan. Parkinsonism & Related Disorders
Nishio Y, Yokoi K, Hirayama K, et al. (2018) Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions. Parkinsonism & Related Disorders
Hattori N, Takeda A, Takeda S, et al. (2018) Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study. Parkinsonism & Related Disorders
Yoshida S, Hasegawa T, Suzuki M, et al. (2018) Parkinson's disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking. Human Molecular Genetics
See more...